Autogenous Vaccine for Aquaculture Market
Autogenous Vaccine for Aquaculture Market Study by Salmon, Tilapia, Bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Cyclopterus Lumpus, and Trout from 2024 to 2034
Analysis of Autogenous Vaccine for Aquaculture Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Autogenous Vaccine for Aquaculture Market Outlook (2024 to 2034)
The global autogenous vaccine for aquaculture market is estimated at a valuation of US$ 14.1 million in 2024 and is forecasted to increase at a 5.3% CAGR to reach US$ 23.7 million by the end of 2034.
The increasing demand for autogenous vaccines for aquaculture is attributed to their use to address some specific diseases prevalent in aquaculture farms. The requirements for efficient measures for disease prevention and control are forecast to stimulate farmers to look for ways to protect their respective aquatic species from any infection.
Rising global consumption of seafood, along with the noteworthy expansion of the aquaculture industry, is set to generate high requirements for effective disease management. Autogenous vaccines play an efficient role in mitigating the impact of disorders on aquaculture protection, therefore supporting the expansion of the autogenous vaccine for aquaculture market size.
- Sales of autogenous vaccines for aquaculture in the United States are projected to rise at a 4.7% CAGR and reach US$ 5 million by the end of 2034.
- Bacteria-based autogenous vaccines for aquaculture are forecast to account for 92.8% share of the global market by 2034.
- Latin America is forecast to account for 11.5% of the global autogenous vaccine for aquaculture market share by 2034.
Autogenous vaccines can be customized as per the presence the specific pathogens on a particular farm. This customization is projected to ensure an effective and targeted response to the existing diseases, therefore making them attractive options for aquaculture farmers. Regulatory bodies are recognizing the importance of autogenous vaccines in disease management, which is further contributing to the autogenous vaccine for aquaculture market growth.
Autogenous vaccines are adopted as an effective alternative to conventional antibiotics in disease management. Increasing concerns about antibiotic resistance, along with a desire to minimize the use of antibiotics on farms in aquaculture, are projected to lead to the growing inclination of farmers toward autogenous vaccines as a sustainable solution.
| Report Attributes | Details |
|---|---|
| Autogenous Vaccine for Aquaculture Market Size (2024E) | US$ 14.1 Million |
| Forecasted Market Value (2034F) | US$ 23.7 Million |
| Global Market Growth Rate (2024 to 2034) | 5.3% CAGR |
| Salmon Segment Market Share (2034F) | 40.4% |
| North America Market Share (2034F) | 25% |
| Chile Market Growth Rate (2024 to 2034) | 4.5% CAGR |
| Key Companies Profiled | IDT Biologika GmbH; Zoetis; Vaccinova; HIPRA; MARINNOVAC; Barramundi Asia Pte Ltd.; Sanphar (ipeve); AniCon Labor GmbH; Kennebec River Biosciences |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Prominent Autogenous Vaccine for Aquaculture Market Trends?
“Resistance to Specific Antibiotics Driving Demand for Autogenous Vaccines for Aquaculture”
A wide variety of new aquaculture vaccines have been developed over the past few years for the management of zoonotic diseases or infection profiling among some aquatic species. Therefore, R&D activities are undertaken for the management and treatment of these disorders. In subtropical or topical areas, there has been a significant increase in the requirement for aquaculture vaccines. This increased demand is attributed to the emergence of resistance to some chemotherapeutic drugs and antibiotics.
The development and commercialization of third-generation DNA vaccines against aquatic pathogens is projected to act as a developing area of R&D activities in autogenous vaccines for aquaculture. Further, these DNA vaccines are forecasted to work as incredibly effective solutions and help in the strengthening of the immune systems of respective species.
What is Denting Autogenous Vaccine for Aquaculture Market Size Expansion?
“Stringent Regulations Governing Vaccine Approval Delaying Commercialization of Vaccines”
Countries have their own regulatory processes and agencies for the approval of autogenous vaccines for aquaculture. Approval processes in various countries serve as a barrier to the commercialization of autogenous vaccines for aquaculture. In addition, the price of the distribution of autogenous vaccines for aquaculture is comparatively high, which makes service providers need to wait for a longer duration to get their profit share.
Companies are prohibited from releasing improved or new products before getting all the permits. These licensing terms are projected to lead to the slow growth of the global market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Initiatives are New Manufacturers Taking to Secure Their Position in the Market?
“Focus on Development of Autogenous Vaccines Tailored to Specific Local Pathogens”
The focus on the development of autogenous vaccines customized according to the specific local pathogens prevalent in several regions is projected to help start-ups secure an important position. In addition, customization can help them address unique challenges encountered in aquaculture operations in different geographical locations.
Exploring innovative technologies for the development, production, and administration of vaccines is projected to help them gain a competitive edge. Advancements in biotechnology, delivery mechanisms, and molecular biology can also help enhance the effectiveness of autogenous vaccines.
Country-wise Insights
North America is forecast to account for 25% share of global market revenue by the end of 2034, as per the study published by Fact.MR. Increasing production, as well as the export of aquaculture in the region, is forecast to generate demand for effective feeds and healthcare facilities, which is projected to contribute to autogenous vaccine sales.
What Makes the United States a Prominent Market in This Business Space?
“Reduced Use of Antibiotics and Supportive Regulations for Vaccine Development”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 3 Million |
| Growth Rate (2024 to 2034) | 4.7% CAGR |
| Projected Value (2034F) | US$ 5 Million |
The United States is forecast to hold 77.6% share of the North American market by 2034.
- According to data provided by the Chilean Salmon Council in 2021, the United States is one of the prominent exporters of salmon around the world.
There is a noteworthy increase in concerns related to antibiotic use in aquaculture, along with their impact on the environment and human health. However, autogenous vaccines offer an alternative approach to disease management, especially minimizing dependency on antibiotics.
Regulatory bodies in the United States are supporting the development of autogenous vaccines, making it comparatively easier for aquaculture producers to adopt these customized solutions. Supportive approvals and guidelines for the use of autogenous vaccines for aquaculture are projected to contribute to revenue streams in the United States.
Why are Manufacturers of Autogenous Vaccines for Aquaculture Investing in Chile?
“Increasing Production and Export of Salmon and Adoption of Advanced Production Techniques”
| Attribute | Chile |
|---|---|
| Market Value (2024E) | US$ 72 Thousand |
| Growth Rate (2024 to 2034) | 4.5% CAGR |
| Projected Value (2034F) | US$ 1.12 Million |
Chile is projected to account for 41% share of the Latin America market by 2034. The prominent position of Chile in the manufacturing and export of salmon is projected to lead to an inclination toward sustainability. The development of sustainable aquaculture in Chile is attributed to its competitive and comparative advantages. In addition, the growing use of salmon for human food and other purposes is contributing to the rising demand for effective healthcare facilities for them.
Prominent salmon farming businesses in the country are agreeing to control carbon and water use and minimize energy consumption. In addition, advanced production facilities have also been implemented, including online environment monitoring, underwater robotics, and many more.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
According to the research analysis published by Fact.MR, a market research and competitive intelligence provider, fish farming companies are forecasted to account for an 81.1% share of the global market by 2034. Noteworthy expansion in aquaculture farming is projected to contribute to the profit share of fish farming companies.
Which Species Accounts for a Significant Share of Global Market Revenue?
“Increased Production of Autogenous Vaccines for Salmon”
| Attribute | Salmon |
|---|---|
| Segment Value (2024E) | US$ 5.3 Million |
| Growth Rate (2024 to 2034) | 6.2% CAGR |
| Projected Value (2034F) | US$ 9.6 Million |
Salmon species are forecast to hold a 40.4% share of the global market by the end of 2034. Growing demand for salmon as one of the most popular seafoods in developed countries is projected to contribute to the rising sales of autogenous vaccines. Furthermore, salmon species are comparatively preferred in aquaculture cultivation in countries such as Norway and Chile.
The steady increase in the production of aquatic creatures, particularly for human consumption, is estimated to lead to the adoption of autogenous vaccines to cure the health issues of respective species.
Which Pathogen Type is in High Demand for Vaccine Production?
“High Demand for Bacterial Conjugate Vaccines Due to Dominance of Bacteria-based Infections”
| Attribute | Bacteria |
|---|---|
| Segment Value (2024E) | US$ 13 Million |
| Growth Rate (2024 to 2034) | 5.4% CAGR |
| Projected Value (2034F) | US$ 22 Million |
Bacteria-based vaccines are forecast to contribute 92.8% share of the global market by 2034.
- Aquatic Animal Health Research by the USDA (United States Department of Agriculture) determined that bacterial species from approximately 20 genera are a significant cause of illnesses in aquatic creatures.
These aquatic diseases are projected to become one of the prominent reasons for huge economic losses in the aquaculture field. Therefore, bacterial conjugate vaccines find widespread usage in aquaculture.
Competitive Landscape
Market players are focusing on strategic acquisitions to leverage innovative and new ideas. They are involved in partnerships to improve the supply chain management system. Key manufacturers are extensively focusing on addressing the requirements of sustainable aquaculture farming with the practical and effective development and manufacturing of autogenous vaccines for aquaculture.
For instance :
- TransAlgae is projected to influence the prospects of vaccination in aquaculture with the introduction of microalgae-based technology for oral delivery in January 2021. TransAlgae and Virbas entered into a collaboration to develop a vaccine with the use of TransAlgae’s innovative technology.
Key players in the autogenous vaccine for aquaculture industry are AniCon Labor GmbH, IDT Biologika GmbH, Zoetis, Vaccinova, HIPRA, MARINNOVAC, Barramundi Asia Pte Ltd., Sanphar (ipeve), and Kennebec River Biosciences.
Segmentation of Autogenous Vaccine for Aquaculture Market Research
-
By Fish Species:
- Salmon
- Tilapia
- Bream
- Labris Bergylta
- Cyprinus Carpio
- Sea Bass
- Cyclopterus Lumpus
- Trout
-
By Pathogen Type:
- Bacteria
- Virus
-
By End User:
- Fish Farming Companies
- Aquatic Research Institutes
-
By Region:
- North America
- Europe
- East Asia
- Latin America
- Middle East & Africa
- South Asia & Oceania
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Fish Species
- 6.1. Salmon
- 6.2. Tilapia
- 6.3. Bream
- 6.4. Labris Bergylta
- 6.5. Cyprinus Carpio
- 6.6. Sea Bass
- 6.7. Cyclopterus Lumpus
- 6.8. Trout
- 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Pathogen Type
- 7.1. Bacteria
- 7.2. Virus
- 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User
- 8.1. Fish Farming Companies
- 8.2. Aquatic Research Institutes
- 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 11. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 12. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. IDT Biologika GmbH
- 17.2. Zoetis
- 17.3. Vaccinova
- 17.4. HIPRA
- 17.5. MARINNOVAC
- 17.6. Barramundi Asia Pte Ltd.
- 17.7. Sanphar (ipeve)
- 17.8. AniCon Labor GmbH
- 17.9. Kennebec River Biosciences
- 18. Assumptions and Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Fish Species, 2018 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Fish Species, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Fish Species, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Pathogen Type, 2018 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Pathogen Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Pathogen Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Fish Species, 2018 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Fish Species, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Fish Species, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Pathogen Type, 2018 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Pathogen Type, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Pathogen Type, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Fish Species, 2018 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Fish Species, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Fish Species, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Pathogen Type, 2018 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Pathogen Type, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Pathogen Type, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Europe Market Value (US$ Mn) Analysis, by Fish Species, 2018 to 2023
Table 41: Europe Market Value (US$ Mn) Analysis, by Fish Species, 2024 to 2034
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Fish Species, 2024 to 2034
Table 43: Europe Market Value (US$ Mn) Analysis, by Pathogen Type, 2018 to 2023
Table 44: Europe Market Value (US$ Mn) Analysis, by Pathogen Type, 2024 to 2034
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Pathogen Type, 2024 to 2034
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Fish Species, 2018 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Fish Species, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Fish Species, 2024 to 2034
Table 55: East Asia Market Value (US$ Mn) Analysis, by Pathogen Type, 2018 to 2023
Table 56: East Asia Market Value (US$ Mn) Analysis, by Pathogen Type, 2024 to 2034
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Pathogen Type, 2024 to 2034
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Fish Species, 2018 to 2023
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Fish Species, 2024 to 2034
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Fish Species, 2024 to 2034
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Pathogen Type, 2018 to 2023
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Pathogen Type, 2024 to 2034
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Pathogen Type, 2024 to 2034
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: MEA Market Value (US$ Mn) Analysis, by Fish Species, 2018 to 2023
Table 77: MEA Market Value (US$ Mn) Analysis, by Fish Species, 2024 to 2034
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Fish Species, 2024 to 2034
Table 79: MEA Market Value (US$ Mn) Analysis, by Pathogen Type, 2018 to 2023
Table 80: MEA Market Value (US$ Mn) Analysis, by Pathogen Type, 2024 to 2034
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Pathogen Type, 2024 to 2034
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Fish Species, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Fish Species, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Fish Species, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Pathogen Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Pathogen Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Pathogen Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Fish Species, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Fish Species, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Fish Species, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Pathogen Type, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Pathogen Type, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Pathogen Type, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Fish Species, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Fish Species, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Fish Species, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Pathogen Type, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Pathogen Type, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Pathogen Type, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Europe Market Share and BPS Analysis by Fish Species, 2024 & 2034
Figure 57: Europe Market Y-o-Y Growth Projections by Fish Species, 2024 to 2034
Figure 58: Europe Market Attractiveness Analysis by Fish Species, 2024 to 2034
Figure 59: Europe Market Share and BPS Analysis by Pathogen Type, 2024 & 2034
Figure 60: Europe Market Y-o-Y Growth Projections by Pathogen Type, 2024 to 2034
Figure 61: Europe Market Attractiveness Analysis by Pathogen Type, 2024 to 2034
Figure 62: Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 64: Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 72: East Asia Market Share and BPS Analysis by Fish Species, 2024 & 2034
Figure 73: East Asia Market Y-o-Y Growth Projections by Fish Species, 2024 to 2034
Figure 74: East Asia Market Attractiveness Analysis by Fish Species, 2024 to 2034
Figure 75: East Asia Market Share and BPS Analysis by Pathogen Type, 2024 & 2034
Figure 76: East Asia Market Y-o-Y Growth Projections by Pathogen Type, 2024 to 2034
Figure 77: East Asia Market Attractiveness Analysis by Pathogen Type, 2024 to 2034
Figure 78: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 80: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Fish Species, 2024 & 2034
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Fish Species, 2024 to 2034
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Fish Species, 2024 to 2034
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Pathogen Type, 2024 & 2034
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Pathogen Type, 2024 to 2034
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Pathogen Type, 2024 to 2034
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2024 & 2034
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2024 to 2034
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 101: MEA Market Share Analysis by Country, 2024 & 2034
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 104: MEA Market Share and BPS Analysis by Fish Species, 2024 & 2034
Figure 105: MEA Market Y-o-Y Growth Projections by Fish Species, 2024 to 2034
Figure 106: MEA Market Attractiveness Analysis by Fish Species, 2024 to 2034
Figure 107: MEA Market Share and BPS Analysis by Pathogen Type, 2024 & 2034
Figure 108: MEA Market Y-o-Y Growth Projections by Pathogen Type, 2024 to 2034
Figure 109: MEA Market Attractiveness Analysis by Pathogen Type, 2024 to 2034
Figure 110: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 112: MEA Market Attractiveness Analysis by End User, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the valuation of the autogenous vaccine for aquaculture market?
The global autogenous vaccine for aquaculture market is estimated at US$ 14.1 million in 2024.
What is the demand valuation for autogenous vaccines for aquaculture for 2034?
Demand for autogenous vaccines for aquaculture is projected to reach a market value of US$ 23.7 million by the end of 2034.
What is the sales forecast for the global market from 2024 to 2034?
Sales of autogenous vaccines for aquaculture are forecasted to increase at 5.3% CAGR from 2024 to 2034.
What share of the market are salmon forecasted to account for by 2034?
Salmon are projected to account for 40.4% share of global market revenue by 2034.
At what rate are the sales of autogenous vaccines for aquaculture projected to increase in Chile?
The market in Chile is forecasted to rise at a CAGR of 4.5% from 2024 to 2034.
What are the benefits of autogenous vaccines?
Autogenous vaccines for aquaculture help reduce production costs, enhance immunity, contribute to public health, and offer prevention instead of cure.
Autogenous Vaccine for Aquaculture Market